Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound , today announced the acceptance of a clinical abstract titled “Thermoacoustic assessment of fatty liver disease - a...

Related Keywords

Slovak Republic ,Prague ,Praha ,Hlavníesto ,Czech Republic ,Czechoslovakia ,Michael Thornton ,Nasdaq ,Life Sciences Inc ,Life Sciences ,Endra Life Sciences Inc ,Securities Exchange ,Exchange Commission ,Thermo Acoustic Enhanced Ultrasound ,Steatotic Liver Disease ,European Association ,Magnetic Resonance Imaging ,Density Fat Fraction ,Chief Technology Officer ,Central European Time ,Securities Act ,Securities Exchange Act ,Risk Factors ,Financial Condition ,Annual Report ,Quarterly Reports ,Markets ,